⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CVM News
Cel-Sci Corporation
Form 8-K
sec.gov
CVM
CEL-SCI Announces Closing of Offering
businesswire.com
CVM
Form 8-K
sec.gov
CVM
Form 8-K
sec.gov
CVM
CEL-SCI Announces Closing of Public Offering
businesswire.com
CVM
CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia
businesswire.com
CVM
$1.59 Billion PD-1 Resistant Head and Neck Cancer Market Analysis Report 2026: Size, Growth, and Segmentation Insights to 2030
globenewswire.com
CVM
EXEL
MRK
PFE
AZN
RPRX
CEL-SCI Reports Fiscal First Quarter 2026 Results
businesswire.com
CVM
CEL-SCI Reports Fiscal First Quarter 2026 Results
businesswire.com
CVM
CEL-SCI Reports Fiscal 2025 Results
businesswire.com
CVM